by Halia Therapeutics | Mar 22, 2023 | News & Media
The Bio Report David Bearss Ph.D., president and CEO of Halia Therapeutics, Inc., discusses with Daniel Levine the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for the company’s therapeutic approach.... by Halia Therapeutics | Mar 22, 2023 | News & Media
Empowered Patient Podcast David Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway... by Halia Therapeutics | Feb 15, 2023 | News & Media
BioSpace Biopharma Execs Adopt Creative Mindset at BIO CEO https://www.biospace.com/article/biopharma-execs-adopt-creative-mindset-at-bio-ceo-/ by Halia Therapeutics | Jan 20, 2023 | News & Media
STAT Up and down the ladder: The latest comings and goings Up and down the ladder: The latest comings and... by Halia Therapeutics | Jan 20, 2023 | News & Media
Fierce Biotech Chutes & Ladders—David Kessler resigns from the Biden admin, marking the unofficial end of Operation Warp Speed... by Halia Therapeutics | Jan 20, 2023 | News & Media
Endpoints News ‘Perfect time’: SIGA’s CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play ‘Perfect time’: SIGA’s CEO on retirement; Juvenescence woos GSK vet to lead anti-aging... by Halia Therapeutics | Jan 20, 2023 | News & Media
The Pharma Letter Amgen’s Margit Janát-Amsbury named Halia CMO https://www.thepharmaletter.com/article/amgen-s-margit-janat-amsbury-named-halia-cmo by Halia Therapeutics | Jan 19, 2023 | News & Media
BioWorld Appointments and advancements for Jan. 19, 2023 https://www.bioworld.com/articles/693419-appointments-and-advancements-for-jan-19-2023?v=preview by Halia Therapeutics | Jan 17, 2023 | News & Media
CFO DIVE Biotech CFOs sharpen financing tactics for lean times https://www.cfodive.com/news/3-biotech-cfos-finding-financing-lean-times/640301/ by Halia Therapeutics | Nov 16, 2022 | News & Media
David J. Bearss, Ph.D., Co-Founder, and CEO of Salt Lake City-based Halia Therapeutics, for his limitless and inspiring entrepreneurial spirit, mentorship, and achievements that are transforming therapeutics, spawning discovery, seeding startups, and strengthening...